These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16765588)

  • 21. TGFbeta1 (Leu10Pro), p53 (Arg72Pro) can predict for increased risk for breast cancer in south Indian women and TGFbeta1 Pro (Leu10Pro) allele predicts response to neo-adjuvant chemo-radiotherapy.
    Rajkumar T; Samson M; Rama R; Sridevi V; Mahji U; Swaminathan R; Nancy NK
    Breast Cancer Res Treat; 2008 Nov; 112(1):81-7. PubMed ID: 18058229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thymidylate synthetase allelic imbalance in clear cell renal carcinoma.
    Colavito D; Cartei G; Dal Bianco M; Stecca A; Zustovich F; Dalle Carbonare M; Ragazzi E; Farina M; Colombrino E; Leon A
    Cancer Chemother Pharmacol; 2009 Nov; 64(6):1195-200. PubMed ID: 19306093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exon 19 of EGFR mutation in relation to the CA-repeat polymorphism in intron 1.
    Sueoka-Aragane N; Imai K; Komiya K; Sato A; Tomimasu R; Hisatomi T; Sakuragi T; Mitsuoka M; Hayashi S; Nakachi K; Sueoka E
    Cancer Sci; 2008 Jun; 99(6):1180-7. PubMed ID: 18422739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Association study on microsatellite polymorphisms of MSX1 gene and nonsyndromic cleft lip and palate].
    Wu PA; Li YL; Fan GZ; Wang K
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Jun; 24(3):325-7. PubMed ID: 17557248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between the length of a CA dinucleotide repeat in the EGFR and risk of breast cancer.
    Jami MS; Hemati S; Salehi Z; Tavassoli M
    Cancer Invest; 2008 May; 26(4):434-7. PubMed ID: 18443966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MHC class I chain-related gene A transmembrane polymorphism in Spanish women with breast cancer.
    Lavado-Valenzuela R; Benavides M; Carabantes F; Alonso A; Caballero A
    Tissue Antigens; 2009 Jul; 74(1):46-9. PubMed ID: 19392799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection and relevance of germline genetic polymorphisms in glutathione S-transferases (GSTs) in breast cancer patients from northern Indian population.
    Saxena A; Dhillon VS; Raish M; Asim M; Rehman S; Shukla NK; Deo SV; Ara A; Husain SA
    Breast Cancer Res Treat; 2009 Jun; 115(3):537-43. PubMed ID: 18574688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defective gammadelta T-cell function and granzyme B gene polymorphism in a cohort of newly diagnosed breast cancer patients.
    Gaafar A; Aljurf MD; Al-Sulaiman A; Iqniebi A; Manogaran PS; Mohamed GE; Al-Sayed A; Alzahrani H; Alsharif F; Mohareb F; Ajarim D; Tabakhi A; Al-Hussein K
    Exp Hematol; 2009 Jul; 37(7):838-48. PubMed ID: 19446661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogen receptor alpha gene polymorphism and breast cancer.
    Siddig A; Mohamed AO; Awad S; Hassan AH; Zilahi E; Al-Haj M; Bernsen R; Adem A
    Ann N Y Acad Sci; 2008 Sep; 1138():95-107. PubMed ID: 18837889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. XPD Lys751Gln polymorphism analysis in women with sporadic breast cancer.
    Romanowicz-Makowska H; Sobczuk A; Smolarz B; Fiks T; Kulig A
    Pol J Pathol; 2007; 58(4):245-9. PubMed ID: 18459458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Shorter CAG repeat in the AR gene is associated with atypical hyperplasia and breast carcinoma.
    De Abreu FB; Pirolo LJ; Canevari Rde A; Rosa FE; Moraes Neto FA; Caldeira JR; Rainho CA; Rogatto SR
    Anticancer Res; 2007; 27(2):1199-205. PubMed ID: 17465263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allelic imbalance in hereditary and sporadic prostate cancer.
    Verhage BA; van Houwelingen K; Ruijter TE; Kiemeney LA; Schalken JA
    Prostate; 2003 Jan; 54(1):50-7. PubMed ID: 12481255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Family-based genetic association study of insulin-like growth factor I microsatellite markers and premenopausal breast cancer risk.
    Fehringer G; Boyd NF; Knight JA; Paterson AD; Dite GS; Giles GG; Southey MC; Andrulis IL; Hopper JL; Ozcelik H
    Breast Cancer Res Treat; 2009 Nov; 118(2):415-24. PubMed ID: 19229608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The association of CYP2D6 *10 polymorphism with breast cancer risk and clinico-pathologic characteristics in Chinese women.
    Li H; Feng L; Xu Y; Yao L; Ouyang T; Li J; Wang T; Fan Z; Lin B; Li J; Xie Y
    Acta Oncol; 2006; 45(5):597-601. PubMed ID: 16864175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. P27 V109G Polymorphism is associated with lymph node metastases but not with increased risk of breast cancer.
    Naidu R; Har YC; Taib NA
    J Exp Clin Cancer Res; 2007 Mar; 26(1):133-40. PubMed ID: 17550142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
    Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
    Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The association between genetic polymorphisms in CYP19 and breast cancer risk in Korean women.
    Kim JY; Lee CS; Kim HO; Jo YH; Lee J; Jung MH; Baik HH; Choe W; Kang I; Yoon KS
    Oncol Rep; 2009 Sep; 22(3):487-92. PubMed ID: 19639193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Polymorphism Lys751Gln of XPD gene and breast cancer risk in women].
    Romanowicz-Makowska H; Smolarz B
    Pol Merkur Lekarski; 2007 Aug; 23(134):107-9. PubMed ID: 18044339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymorphism of ZuBeCa3 microsatellite and its association with mammary tumor in dogs.
    Bhattacharya TK; Rani S; Maiti SK; Dayal S; Kumar P; Sharma A
    Int J Immunogenet; 2007 Jun; 34(3):161-5. PubMed ID: 17504505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Shorter CAG repeat length in the AR gene is associated with poor outcome in head and neck cancer.
    Rosa FE; dos Santos RM; Poli-Frederico RC; Canevari Rde A; Nishimoto IN; Magrin J; Rainho CA; Kowalski LP; Rogatto SR
    Arch Oral Biol; 2007 Aug; 52(8):732-9. PubMed ID: 17321486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.